$ARMP
Armata Pharmaceuticals, Inc.

2014 Form 10-K Financial Statement

#000114420415023071 Filed on April 15, 2015

View on sec.gov

Income Statement

Concept 2014 2013 Q4 2013
Revenue $409.0K -$250.0K $81.00K
YoY Change 404.94% -1350.0% -87.73%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.850M $1.250M $6.000M
YoY Change 14.17% 35.87% 88.68%
% of Gross Profit
Research & Development $5.805M $1.200M $6.469M
YoY Change -10.26% 114.29% 337.09%
% of Gross Profit
Depreciation & Amortization $127.0K $10.00K $82.00K
YoY Change 54.88% -50.0% 36.67%
% of Gross Profit
Operating Expenses $14.52M $2.450M $12.47M
YoY Change 16.48% 65.54% 167.49%
Operating Profit -$14.11M -$12.38M
YoY Change 13.94%
Interest Expense $0.00 $3.110M $233.0K
YoY Change -100.0% -3555.56% -168.53%
% of Operating Profit
Other Income/Expense, Net -$37.22M $20.00K $52.20M
YoY Change -171.3% -84.62% 40053.08%
Pretax Income $23.11M $430.0K -$64.58M
YoY Change -135.78% -129.66% 1426.71%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $23.11M $430.0K -$64.58M
YoY Change -135.78% -129.66% 5879.91%
Net Earnings / Revenue 5650.12% -79732.1%
Basic Earnings Per Share $0.12 -$0.64
Diluted Earnings Per Share $0.07 $21.50M -$0.64
COMMON SHARES
Basic Shares Outstanding 187.3M shares 101.2M shares
Diluted Shares Outstanding 323.6M shares 101.2M shares

Balance Sheet

Concept 2014 2013 Q4 2013
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.581M $20.36M $20.36M
YoY Change -67.68% 2267.44% 2267.44%
Cash & Equivalents $6.581M $20.36M $20.36M
Short-Term Investments
Other Short-Term Assets $339.0K $300.0K $300.0K
YoY Change 13.0% -61.04% -61.04%
Inventory
Prepaid Expenses
Receivables $0.00 $8.000K $10.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.020M $20.66M $20.66M
YoY Change -66.02% 1152.12% 1152.12%
LONG-TERM ASSETS
Property, Plant & Equipment $1.220M $145.0K $150.0K
YoY Change 713.33% 3.57% 7.14%
Goodwill $7.562M
YoY Change
Intangibles $12.45M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $21.60M $20.55M $20.55M
YoY Change 5.09% 0.65% 0.64%
TOTAL ASSETS
Total Short-Term Assets $7.020M $20.66M $20.66M
Total Long-Term Assets $21.60M $20.55M $20.55M
Total Assets $28.62M $41.21M $41.21M
YoY Change -30.56% 86.74% 86.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $2.150M $2.150M
YoY Change -100.0% 10.82% 10.82%
Accrued Expenses $457.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.868M $2.391M $2.390M
YoY Change -21.84% -60.48% -60.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $18.24M $57.66M $57.66M
YoY Change -68.36%
Total Long-Term Liabilities $18.24M $51.11M $57.66M
YoY Change -68.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.868M $2.391M $2.390M
Total Long-Term Liabilities $18.24M $51.11M $57.66M
Total Liabilities $23.19M $63.13M $63.13M
YoY Change -63.27% 591.47% 591.46%
SHAREHOLDERS EQUITY
Retained Earnings -$385.1M
YoY Change
Common Stock $1.825M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.427M -$22.63M -$21.92M
YoY Change
Total Liabilities & Shareholders Equity $28.62M $41.21M $41.21M
YoY Change -30.56% 86.74% 86.72%

Cashflow Statement

Concept 2014 2013 Q4 2013
OPERATING ACTIVITIES
Net Income $23.11M $430.0K -$64.58M
YoY Change -135.78% -129.66% 5879.91%
Depreciation, Depletion And Amortization $127.0K $10.00K $82.00K
YoY Change 54.88% -50.0% 36.67%
Cash From Operating Activities -$12.57M -$1.410M -$6.290M
YoY Change 99.87% -5.37% 46.96%
INVESTING ACTIVITIES
Capital Expenditures $1.202M $0.00 $102.0K
YoY Change 1078.43% -100.0% -304.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$1.202M $0.00 -$100.0K
YoY Change 1102.0% -100.0% -103.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $16.89M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 16.92M 25.89M
YoY Change -100.0% 2625.26%
NET CHANGE
Cash From Operating Activities -12.57M -1.410M -6.290M
Cash From Investing Activities -1.202M 0.000 -100.0K
Cash From Financing Activities 0.000 16.92M 25.89M
Net Change In Cash -13.77M 15.51M 19.50M
YoY Change -170.64% -1134.0% -8578.26%
FREE CASH FLOW
Cash From Operating Activities -$12.57M -$1.410M -$6.290M
Capital Expenditures $1.202M $0.00 $102.0K
Free Cash Flow -$13.77M -$1.410M -$6.392M
YoY Change 115.49% -4.73% 51.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2147000 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1167000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
0 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
457000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2391000 USD
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes and management must select an amount that falls within that range of reasonable estimates. This process may result in actual results differing materially from those estimated amounts used in the preparation of the financial statements if these results differ from historical experience, or other assumptions do not turn out to be substantially accurate, even if such assumptions are reasonable when made. In preparing these financial statements, management used significant estimates in the following areas, among others: the determination of the fair value of stock-based awards, the fair value of liability-classified preferred stock derivatives, the fair value of liability-classified warrants, the valuation of long-lived assets, including in-process research and development (IPR&amp;D), patents and goodwill, accrued expenses and the recoverability of the Company's net deferred tax assets and related valuation allowance.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
1825000 USD
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12446000 USD
CY2013Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
400000 USD
CY2014Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
369000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
7562000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
7562000 USD
CY2013Q4 us-gaap Assets
Assets
41213000 USD
CY2014Q4 us-gaap Assets
Assets
28617000 USD
CY2014 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
27763000 USD
CY2014Q4 aphb Derivative Preferred Shares Conversion Liability
DerivativePreferredSharesConversionLiability
12320000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20355000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6581000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
297000 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
339000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
20660000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
7020000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
145000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1220000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12446000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1868000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
63131000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
23190000 USD
CY2013Q4 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
707000 USD
CY2014Q4 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
1990000 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
1992000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
358828000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
363451000 USD
CY2013Q4 us-gaap Other Additional Capital
OtherAdditionalCapital
1837000 USD
CY2014Q4 us-gaap Other Additional Capital
OtherAdditionalCapital
0 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-385115000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-362006000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-22625000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
3437000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41213000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28617000 USD
CY2014 us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
388000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
22034747 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
39250000 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
38890452 shares
CY2014Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
100175199 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0.50
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2219000 USD
CY2014 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2013Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000 shares
CY2014Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000 shares
CY2013Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
8859978 shares
CY2014Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
8671040 shares
CY2013Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
8859978 shares
CY2014Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
8671040 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
445000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
445000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
182535562 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
199159093 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
182535562 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
199159093 shares
CY2013 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
81000 USD
CY2014 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
409000 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6469000 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5805000 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5996000 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6850000 USD
CY2013 us-gaap Severance Costs1
SeveranceCosts1
0 USD
CY2014 us-gaap Severance Costs1
SeveranceCosts1
1864000 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
12465000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
14519000 USD
CY2013 us-gaap Interest Expense
InterestExpense
233000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-14110000 USD
CY2013 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-49330000 USD
CY2014 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
37219000 USD
CY2013 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
2636000 USD
CY2014 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
0 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-12384000 USD
CY2014 us-gaap Interest Expense
InterestExpense
0 USD
CY2013 us-gaap Other Expenses
OtherExpenses
52199000 USD
CY2014 us-gaap Other Expenses
OtherExpenses
-37219000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-64583000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
23109000 USD
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101201753 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
187331969 shares
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101201753 shares
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
323604642 shares
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
12943000 USD
CY2014 aphb Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1595000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
2635000 USD
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3000000 USD
CY2013 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2013 aphb Stock Issued During Period Value New Issues1
StockIssuedDuringPeriodValueNewIssues1
0 USD
CY2013 aphb Stock Issued During Period Value Conversion Of Convertible Securities1
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities1
7084000 USD
CY2014 aphb Stock Issued During Period Value Conversion Of Convertible Securities1
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities1
707000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1437000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
775000 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000 USD
CY2013 aphb Stock Issued During Period Value Shares Released From Escrow
StockIssuedDuringPeriodValueSharesReleasedFromEscrow
0 USD
CY2014 aphb Stock Issued During Period Value Shares Released From Escrow
StockIssuedDuringPeriodValueSharesReleasedFromEscrow
0 USD
CY2013 aphb Stock Issued During Period Value New Issues2
StockIssuedDuringPeriodValueNewIssues2
15464000 USD
CY2013 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
0 USD
CY2014 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1161000 USD
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
3000000 USD
CY2014 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
31000 USD
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
31000 USD
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2636000 USD
CY2014 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2013 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
759000 USD
CY2014 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2013 us-gaap Depreciation
Depreciation
82000 USD
CY2014 us-gaap Depreciation
Depreciation
127000 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
1437000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
775000 USD
CY2013 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15000 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
92000 USD
CY2013 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-618000 USD
CY2014 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
454000 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-977000 USD
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
555000 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
149000 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
42000 USD
CY2013 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
233000 USD
CY2014 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6292000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-12572000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
102000 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1202000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-102000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1202000 USD
CY2013 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
7000000 USD
CY2014 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2013 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2000000 USD
CY2014 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
25887000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
0 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
19493000 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-13774000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
862000 USD
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Registrant Name
EntityRegistrantName
AmpliPhi Biosciences Corp
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0000921114
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q2 dei Entity Public Float
EntityPublicFloat
62219991 USD
CY2014 dei Trading Symbol
TradingSymbol
APHB
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
277946973 shares
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-65201000 USD
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
21824000 USD
CY2013 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
618000 USD
CY2014 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1285000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1936000 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1437000 USD
CY2013 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
6316000 USD
CY2014 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2013 aphb Warrant Exercised
WarrantExercised
0 USD
CY2014 aphb Warrant Exercised
WarrantExercised
1595000 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
244000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
244000 USD
CY2013Q4 aphb Preffered B Stock Conversion Liability
PrefferedBStockConversionLiability
40791000 USD
CY2014Q4 aphb Preffered B Stock Conversion Liability
PrefferedBStockConversionLiability
12320000 USD
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
16871000 USD
CY2014Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5826000 USD
CY2013Q4 aphb Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
0 USD
CY2014Q4 aphb Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
98000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3078000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3078000 USD
CY2013Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
13022000 USD
CY2014Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
14042000 USD
CY2013 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-155000 USD
CY2014 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 USD
CY2013 aphb Proceeds From December Financing Activities
ProceedsFromDecemberFinancingActivities
16887000 USD
CY2014 aphb Proceeds From December Financing Activities
ProceedsFromDecemberFinancingActivities
0 USD
us-gaap Severance Costs1
SeveranceCosts1
1864000 USD
CY2014 aphb Payment To Shareholders
PaymentToShareholders
569000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
496000 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1698000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
351000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
478000 USD
CY2014Q4 aphb Consolidated Net Fixed Assets
ConsolidatedNetFixedAssets
1161000 USD
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
314000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Next Rolling Twelve Months
OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths
71000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Two
OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo
44000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Three
OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree
44000 USD
CY2014Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
3155000 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
60708000 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
63405000 USD
CY2013 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.006 pure
CY2014 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.013 pure
CY2013 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P4Y
CY2014 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P4Y
CY2013 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.0 pure
CY2014 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.0 pure
CY2013 aphb Payments For Services Under Collaborative Agreement
PaymentsForServicesUnderCollaborativeAgreement
309000 USD
CY2014 aphb Payments For Services Under Collaborative Agreement
PaymentsForServicesUnderCollaborativeAgreement
207000 USD
CY2013 us-gaap Payments For Royalties
PaymentsForRoyalties
357000 USD
CY2014 us-gaap Payments For Royalties
PaymentsForRoyalties
941000 USD
CY2013 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
168000 USD
CY2014 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
182000 USD
CY2013Q4 aphb Fees For Commencement Of First Phase
FeesForCommencementOfFirstPhase
2500000 USD
CY2013Q4 aphb Fees To Be Paid On First Regulatory Approval
FeesToBePaidOnFirstRegulatoryApproval
5000000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Four
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour
43000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Five
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive
5000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
207000 USD
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
214000 USD
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1371164 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1369164 shares
CY2014 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
13000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
59051000 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
61332000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3700000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3855000 USD
CY2013Q4 aphb Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
4000 USD
CY2014Q4 aphb Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
8000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1121000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1381000 USD
CY2013Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
3162000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
63786000 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
66483000 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-3078000 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-3078000 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2014Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1.40
CY2014 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
1202000 USD
CY2014 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
-127000 USD
CY2014 aphb Property Plant And Equipment Net Additions
PropertyPlantAndEquipmentNetAdditions
1202000 USD
CY2014 aphb Property Plant And Equipment Net Depreciation
PropertyPlantAndEquipmentNetDepreciation
-127000 USD
CY2013 aphb Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.021 pure
CY2014 aphb Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.010 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.037 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.037 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.108 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.162 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2014Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
178000000 USD
CY2014 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
3900000 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
3300000 USD
CY2014Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
2500000 USD
CY2014 aphb Employee Benefits Cash Compensation
EmployeeBenefitsCashCompensation
703000 USD
CY2014 aphb Payments For Severance Costs
PaymentsForSeveranceCosts
148000 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.248 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.549 pure
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
21849294 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
639000 USD
CY2013 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
14214000 USD
CY2013Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
57662000 USD
CY2014Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
18146000 USD
CY2013 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
1.77 pure
CY2014 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.91 pure
CY2013Q4 us-gaap Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
0.14
CY2014Q4 us-gaap Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
0.14
CY2013Q4 us-gaap Share Price
SharePrice
0.50
CY2014Q4 us-gaap Share Price
SharePrice
0.21
CY2014 aphb Employee Benefit Accured Liabilities
EmployeeBenefitAccuredLiabilities
555000 USD
CY2014 aphb Additions Accumulated Depreciation
AdditionsAccumulatedDepreciation
0 USD
CY2014 aphb Depreciation Expense Gross Fixed Assets
DepreciationExpenseGrossFixedAssets
0 USD

Files In Submission

Name View Source Status
0001144204-15-023071-index-headers.html Edgar Link pending
0001144204-15-023071-index.html Edgar Link pending
0001144204-15-023071.txt Edgar Link pending
0001144204-15-023071-xbrl.zip Edgar Link pending
aphb-20141231.xml Edgar Link completed
aphb-20141231.xsd Edgar Link pending
aphb-20141231_cal.xml Edgar Link unprocessable
aphb-20141231_def.xml Edgar Link unprocessable
aphb-20141231_lab.xml Edgar Link unprocessable
aphb-20141231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpg10a.jpg Edgar Link pending
tpg10b.jpg Edgar Link pending
tpg11a.jpg Edgar Link pending
tpg11b.jpg Edgar Link pending
tpg14.jpg Edgar Link pending
v407144_10k.htm Edgar Link pending
v407144_ex14-1.htm Edgar Link pending
v407144_ex23-1.htm Edgar Link pending
v407144_ex23-2.htm Edgar Link pending
v407144_ex3-5.htm Edgar Link pending
v407144_ex31-1.htm Edgar Link pending
v407144_ex31-2.htm Edgar Link pending
v407144_ex32-1.htm Edgar Link pending
v407144_ex32-2.htm Edgar Link pending